Provided by Tiger Trade Technology Pte. Ltd.

Nautilus Biotechnolgy, Inc.

0.9545
+0.05225.79%
Post-market: 0.97820.0237+2.48%19:58 EDT
Volume:852.12K
Turnover:807.21K
Market Cap:121.30M
PE:-2.14
High:0.9782
Open:0.9200
Low:0.8900
Close:0.9023
52wk High:4.31
52wk Low:0.6200
Shares:127.08M
Float Shares:63.02M
Volume Ratio:1.63
T/O Rate:1.35%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-0.4464
EPS(LYR):-0.4673
ROE:-36.21%
ROA:-20.83%
PB:0.93
PE(LYR):-2.04

Loading ...

Company Profile

Company Name:
Nautilus Biotechnolgy, Inc.
Exchange:
NASDAQ
Establishment Date:
2016
Employees:
127
Office Location:
2701 Eastlake Avenue East,Seattle,Washington,United States
Zip Code:
98102
Fax:
- -
Introduction:
Nautilus Biotechnology, Inc., a development stage life sciences company, engages in creating a platform technology for quantifying and unlocking the complexity of the proteome. It develops Nautilus Platform, a proteomics platform that includes end-to-end solution comprised of instruments, consumables, and software analysis. The company was incorporated in 2016 and is headquartered in Seattle, Washington.

Directors

Name
Position
Adam Stone
Chief Executive Officer and Director
Joseph Edelman
Chairman
Michael Altman
Chief Financial Officer and Director
Bradley L. Campbell
Director
Saqib Islam
Director
Todd Wider
Director

Shareholders

Name
Position
Adam Stone
Chief Executive Officer and Director
Michael Altman
Chief Financial Officer and Director
Konstantin Poukalov
Chief Business Officer